SLC16A1 and diffuse large B-cell lymphoma: To further confirm the phenotypic efficacy of AZD3965 and to build understanding of mechanisms that determine sensitivity to AZD3965, a panel of DLBCL, NHL and Burkitt’s lymphoma cell lines (Supplementary Table 1) positive for MCT1 protein expression were assayed for cell number following 72 hr incubation with AZD3965.